EP 3082818 A1 20161026 - USE OF PAR-1 ANTAGONISTS FOR PREVENTING AND/OR TREATING PELVI-PERINEAL FUNCTIONAL PATHOLOGICAL CONDITIONS
Title (en)
USE OF PAR-1 ANTAGONISTS FOR PREVENTING AND/OR TREATING PELVI-PERINEAL FUNCTIONAL PATHOLOGICAL CONDITIONS
Title (de)
VERWENDUNG VON PAR-1-ANTAGONISTEN ZUR PRÄVENTION UND/ODER BEHANDLUNG VON PELVI-PERINEALEN FUNKTIONELLEN PATHOLOGISCHEN STÖRUNGEN
Title (fr)
UTILISATION D'ANTAGONISTES PAR-1 POUR LA PREVENTION ET/OU LE TRAITEMENT DES PATHOLOGIES FONCTIONNELLES PELVI-PERINEALES
Publication
Application
Priority
- FR 1362682 A 20131216
- EP 2014073453 W 20141031
Abstract (en)
[origin: CA2931161A1] The present invention relates to the use of PAR1 antagonists, in particular of vorapaxar, of atopaxar and of 3-(2-chlorophenyl)-1-[4-(4-fluorobenzyl)piperazin-1-yl]propenone, or a pharmaceutically acceptable salt thereof, for preventing and/or treating pelvi-perineal functional pathological conditions, and more particularly painful bladder syndrome.
IPC 8 full level
A61K 31/4965 (2006.01); A61P 13/00 (2006.01); A61P 13/10 (2006.01)
CPC (source: EP KR RU US)
A61K 9/0034 (2013.01 - KR); A61K 31/343 (2013.01 - KR); A61K 31/4355 (2013.01 - KR); A61K 31/443 (2013.01 - EP RU US); A61K 31/495 (2013.01 - EP KR RU US); A61K 31/496 (2013.01 - KR); A61K 31/497 (2013.01 - EP US); A61K 31/506 (2013.01 - EP US); A61K 31/5377 (2013.01 - EP KR RU US); A61P 13/00 (2018.01 - EP RU US); A61P 13/10 (2018.01 - EP RU US); A61P 15/00 (2018.01 - RU); A61P 15/12 (2018.01 - RU)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
FR 3014693 A1 20150619; FR 3014693 B1 20160108; AU 2014365665 A1 20160714; AU 2014365665 B2 20190829; CA 2931161 A1 20150625; CN 105813642 A 20160727; CN 105813642 B 20190503; EP 3082818 A1 20161026; HK 1221913 A1 20170616; IL 246216 A0 20160731; JP 2016540799 A 20161228; JP 6612233 B2 20191127; KR 20160089518 A 20160727; MA 39072 A1 20170531; MX 2016007795 A 20160907; MX 370061 B 20191129; RU 2678309 C1 20190125; SA 516371348 B1 20191110; TN 2016000196 A1 20171006; UA 120603 C2 20200110; US 10265322 B2 20190423; US 2016287603 A1 20161006; US 2018311253 A1 20181101; US 9980970 B2 20180529; WO 2015090705 A1 20150625
DOCDB simple family (application)
FR 1362682 A 20131216; AU 2014365665 A 20141031; CA 2931161 A 20141031; CN 201480068095 A 20141031; EP 14793086 A 20141031; EP 2014073453 W 20141031; HK 16110155 A 20160825; IL 24621616 A 20160614; JP 2016540042 A 20141031; KR 20167017262 A 20141031; MA 39072 A 20141031; MX 2016007795 A 20141031; RU 2016127158 A 20141031; SA 516371348 A 20160616; TN 2016000196 A 20141031; UA A201607312 A 20141031; US 201415101170 A 20141031; US 201815962837 A 20180425